BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Diferuloylmethane {Curcumin} - Enterococcus faecalis CBRD01 |
👶
Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity. Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 13 Issue 7 Pages: Pub: 2020 Jul 16 Epub: 2020 Jul 16 Authors Adamczak A , Ozarowski M , Karpinski TM , Html Article Publication |
| Diferuloylmethane {Curcumin} - Enterococcus faecalis CBRD01 |
👶
Olive oil nanoemulsion containing curcumin: antimicrobial agent against multidrug-resistant bacteria. Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 108 Issue 1 Pages: 241 Pub: 2024 Feb 27 Epub: 2024 Feb 27 Authors Confessor MVA , Agreles MAA , Campos LAA , Silva Neto AF , Borges JC , Martins RM , Scavuzzi AML , Lopes ACS , Kretzschmar EAM , Cavalcanti IMF , Html Article Publication |
| Diferuloylmethane {Curcumin} - Enterococcus faecalis CBRD01 |
👶
Curcumin carbon dots inhibit biofilm formation and expression of esp and gelE genes of Enterococcusfaecium. Microbial pathogenesis (Microb Pathog ) Vol: 173 Issue Pt A Pages: 105860 Pub: 2022 Dec Epub: 2022 Oct 29 Authors Sadaqat MH , Mobarez AM , Nikkhah M , Publication |
| Diferuloylmethane {Curcumin} - Enterococcus faecalis CBRD01 |
👶
Efficacy of contemporary and novel Intracanal medicaments against enterococcus faecalis. The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 39 Issue 1 Pages: 47-50 Pub: 2014 Fall Epub: Authors Marickar RF , Geetha RV , Neelakantan P , Publication |
| Diferuloylmethane {Curcumin} - Enterococcus faecalis CBRD01 |
👶
Effectiveness of curcumin against Enterococcus faecalis biofilm. Acta odontologica Scandinavica (Acta Odontol Scand ) Vol: 71 Issue 6 Pages: 1453-7 Pub: 2013 Nov Epub: 2013 Feb 11 Authors Neelakantan P , Subbarao C , Sharma S , Subbarao CV , Garcia-Godoy F , Gutmann JL , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
